Skip to main content

Table 4 Proportions of adverse events by treatment group during follow-up

From: Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children

  DHA/PQP (N = 199) AL (N = 100) p- Value
Anorexia 6.8% 8.3% 0.24
Cough 21.2% 15.4% 0.04
Diarrhoea 7.1% 3.8% 0.051
Fever 12.0% 14.4% 0.32
Respiratory tract infections 11.1% 8.7% 0.20
Vomiting 2.6% 3.8% 0.29